Medical Countermeasures U.S. Replenishes Smallpox and Mpox Vaccine Stockpile in $52.7 Million Contract AwardGlobal Biodefense StaffJune 29, 2026
Industry News U.S. Expands Botulism Antitoxin Stockpile With $64.5 Million Contract AwardGlobal Biodefense StaffMay 28, 2026
Medical Countermeasures Saudi Arabia Clears Smallpox and Mpox Vaccine in Signal of Broadening Biodefense PreparednessGlobal Biodefense StaffMay 18, 2026
Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense Stockpiles Medical Countermeasures March 25, 2026 …
U.S. Government Expands Smallpox Stockpile With $54 Million VIGIV Contract, International Orders Add $6.6 Million Industry News March 25, 2026 …
Mpox Antiviral Clinical Trial Advances as WHO Extends Global Emergency Medical Countermeasures July 17, 2025 …
Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical Countermeasures Medical Countermeasures March 18, 2025 …
Bolstering Pandemic Preparedness: HHS Funds Accelerated Development of H5N1 Vaccine Medical Countermeasures January 17, 2025 …
Diagnosing Difficult-to-detect Pathogens in Central Nervous System Infections Biodetection November 13, 2024 …
FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu Vaccine Medical Countermeasures November 11, 2024 …
GigaGen Wins BARDA Contract to Develop Biothreat Countermeasures Medical Countermeasures October 3, 2024 …
Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
Thylacine Biotherapeutics Earns Top Honor in Medical Threat Reduction Challenge Medical Countermeasures July 9, 2024 …
Maxwell Biosciences Enters CRADA with USAMRIID to Test Potential Therapeutics Industry News May 8, 2024 …
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 Medical Countermeasures May 6, 2024 …
Soligenix Extends Patent Protection for Filovirus Vaccine Platform to UK and South Africa Industry News April 25, 2024 …
Chikungunya Vaccine Candidate Granted Accelerated Review by EMA Medical Countermeasures February 23, 2024 …
NIH Funds Continued Development of Maxim Bio’s At-Home Test for COVID and Flu Biodetection February 1, 2024 …
Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UK Medical Countermeasures January 24, 2024 …
